Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors

被引:112
作者
Jung, MY
Skryabin, BV
Arai, M
Abbondanzo, S
Fu, D
Brosius, J
Robakis, NK
Polites, HG
Pintar, JE
Schmauss, C
机构
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA
[3] Mt Sinai Sch Med, Brookdale Ctr Dev & Mol Biol, New York, NY 10029 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA
[5] Hoechst Marion Roussel Inc, Bridgewater, NJ 08807 USA
关键词
gene targeting; homologous recombination; dopamine D-2 receptors; dopamine D-3 receptors; locomotion; dopamine metabolism;
D O I
10.1016/S0306-4522(98)00705-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Within the D-2-class of dopamine receptors, the D-2 and D-3 subtypes share the highest degree of similarity in their primary structure. However, the extent to which these two receptor subtypes have similar or different functional properties is unclear. The present study used gene targeting to generate mice deficient for D-2, D-3, and D-2/D-3 receptors. A comparative analysis of D-2 and D-3 single mutants and D-2/D-3 double mutants revealed that D-2/D-3 double mutants develop motor phenotypes that, although qualitatively similar to those seen in D-2 single mutants, are significantly more severe. Furthermore, increased levels of the dopamine metabolites dihydroxyphenyl acetic acid and homovanillic acid are found in the dorsal striatum of D-2 single mutants. The levels of these metabolites, however, are significantly higher in mice lacking D-2 and D-3 receptors. In addition, results of immunoprecipitation experiments revealed that D-2 single mutants express higher levels of D-3 receptor proteins during later stages of their postnatal development. These results suggest that D-3 receptors compensate for some of the lacking D-2 receptor functions and that these functional properties of D-3 receptors, detected in mice with a D-2 mutant genetic background, remain masked when the abundant D-2 receptor is expressed. (C) 1999 IBRO. Published by Elsevier Science Ltd.
引用
收藏
页码:911 / 924
页数:14
相关论文
共 37 条
  • [1] A targeted mutation of the D-3 dopamine receptor gene is associated with hyperactivity in mice
    Accili, D
    Fishburn, CS
    Drago, J
    Steiner, H
    Lachowicz, JE
    Park, BH
    Gauda, EB
    Lee, EJ
    Cool, MH
    Sibley, DR
    Gerfen, CR
    Westphal, H
    Fuchs, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 1945 - 1949
  • [2] BALK JH, 1995, NATURE, V377, P424
  • [3] CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA
    BUNZOW, JR
    VANTOL, HHM
    GRANDY, DK
    ALBERT, P
    SALON, J
    CHRISTIE, MJ
    MACHIDA, CA
    NEVE, KA
    CIVELLI, O
    [J]. NATURE, 1988, 336 (6201) : 783 - 787
  • [4] LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS
    BURRIS, KD
    PACHECO, MA
    FILTZ, TM
    KUNG, MP
    KUNG, HF
    MOLINOFF, PB
    [J]. NEUROPSYCHOPHARMACOLOGY, 1995, 12 (04) : 335 - 345
  • [5] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [6] IODINATED 2-AMINOTETRALINS AND 3-AMINO-1-BENZOPYRANS - LIGANDS FOR DOPAMINE D2 AND D3 RECEPTORS
    CHUMPRADIT, S
    KUNG, MP
    VESSOTSKIE, J
    FOULON, C
    MU, M
    KUNG, HF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (24) : 4245 - 4250
  • [7] CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281
  • [8] ALTERED STRIATAL FUNCTION IN A MUTANT MOUSE LACKING D-1A DOPAMINE-RECEPTORS
    DRAGO, J
    GERFEN, CR
    LACHOWICZ, JE
    STEINER, H
    HOLLON, TR
    LOVE, PE
    OOI, GT
    GRINBERG, A
    LEE, EJ
    HUANG, SP
    BARTLETT, PF
    JOSE, PA
    SIBLEY, DR
    WESTPHAL, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12564 - 12568
  • [9] INFLUENCE OF ACUTE AND CHRONIC HALOPERIDOL TREATMENT ON DOPAMINE METABOLISM IN THE RAT CAUDATE-PUTAMEN, PREFRONTAL CORTEX AND AMYGDALA
    ESSIG, EC
    KILPATRICK, IC
    [J]. PSYCHOPHARMACOLOGY, 1991, 104 (02) : 194 - 200
  • [10] FISHBURN CS, 1993, J BIOL CHEM, V268, P5872